Default company panoramic image
Logo

PCAsso Diagnostics

PCAsso is developing PolyChromatic Angiography (PCA) the next generation angiography.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Employees 3
  • Website pcasso.org

Company Summary

PCAsso Diagnostics LLC is a New Jersey diagnostics company developing novel and disruptive diagnostic technology, PCA. PCA is an angiography contrast agent technology that will allow stratification of disease severity based on the degree of vascular pathology. PCA will be used initially for retinal disease (diabetic retinopathy, AMD, uveitis and others) and is expected to produce a paradigm shift in the management of these diseases.

Team

  • Default avatar
    Gregory Van Kipnis
    Advisory Board

  • Default avatar
    Samir Tari
    CEO

  • Default avatar
    C Michael Samson
    Advisory Board

  • Default avatar
    Gaetano Barile
    Advisory Board

  • Default avatar
    Uday Kompella
    Advisory Board

  • Default avatar
    Barbara Araneo
    Advisory Board

  • Default avatar
    Steve Carchedi
    Advisory Board

Advisors

  • Default avatar
    Amper, Politziner & Mattia
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Samir Tari
    Unconfirmed
    Default avatar
    Angel Investors
    Unconfirmed
    Default avatar
    Non-for-profit foundation (JDRF)
    Unconfirmed